Novavax Inc (NVAX)
6.04
+0.28 (+4.86%)
USD |
NASDAQ |
Mar 24, 16:00
6.04
0.00 (0.00%)
After-Hours: 20:00
Novavax Gross Profit Margin (Quarterly): 49.14% for Dec. 31, 2022
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2022 | 49.14% |
| September 30, 2022 | 40.84% |
| June 30, 2022 | -45.80% |
| March 31, 2022 | 97.84% |
| December 31, 2021 | |
| September 30, 2021 | |
| June 30, 2021 | |
| March 31, 2021 | |
| December 31, 2020 | |
| September 30, 2020 | |
| June 30, 2020 | |
| March 31, 2020 | |
| December 31, 2019 | |
| September 30, 2019 | |
| June 30, 2019 | |
| March 31, 2019 | |
| December 31, 2018 | |
| September 30, 2018 | |
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 | |
| September 30, 2017 | |
| June 30, 2017 | |
| March 31, 2017 | |
| December 31, 2016 |
| Date | Value |
|---|---|
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | |
| September 30, 2015 | |
| June 30, 2015 | |
| March 31, 2015 | |
| December 31, 2014 | |
| September 30, 2014 | 50.97% |
| June 30, 2014 | 38.22% |
| March 31, 2014 | 59.51% |
| December 31, 2013 | |
| September 30, 2013 | 52.60% |
| June 30, 2013 | 53.78% |
| March 31, 2013 | 55.34% |
| December 31, 2012 | 57.25% |
| September 30, 2012 | 33.43% |
| June 30, 2012 | 27.95% |
| March 31, 2012 | 18.44% |
| December 31, 2011 | 44.57% |
| September 30, 2011 | 56.27% |
| June 30, 2011 | 58.98% |
| March 31, 2011 | 58.87% |
| December 31, 2010 | |
| September 30, 2010 |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
-45.80%
Minimum
Jun 2022
97.84%
Maximum
Mar 2022
35.51%
Average
44.99%
Median
Gross Profit Margin (Quarterly) Benchmarks
| Moderna Inc | 62.75% |
| Pfizer Inc | 60.28% |
| Johnson & Johnson | 67.24% |
| Merck & Co Inc | 71.94% |
| Inovio Pharmaceuticals Inc | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Assets | -26.19% |
| Profit Margin (Quarterly) | -50.99% |
| Operating Margin (Quarterly) | -68.24% |
| Return on Net Operating Assets | -55.74% |